Status:
COMPLETED
A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza
Lead Sponsor:
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Conditions:
Influenza
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Analyse the time of flu symptom relief in adults with uncomplicated acute influenza,to evaluate the antiviral effects of high and low doses of GP681 tablets, and explore the optimal dose for phase III...
Eligibility Criteria
Inclusion
- Positive Influenza rapid antigen test;
- Fever (axillary temperature ≥37.3℃) or the axillary temperature ≥37.3℃ after taking the medicine for more than 4 hours;
- At least one systemic symptom and respiratory symptom related to a moderate or above influenza virus infection:
- Systemic symptoms: headache, fever or chills, muscle or joint aches, fatigue;
- Respiratory system symptoms: cough, sore throat, nasal congestion.
- Time of disease symptoms ≤48h
Exclusion
- Diagnosed as severe influenza patient ;
- Known history of dysphagia or any gastrointestinal disease that affects drug absorption (including but not limited to reflux esophagitis, chronic diarrhea, inflammatory bowel disease, intestinal tuberculosis, gastrinoma, short bowel syndrome, stomach After subtotal resection, etc.);
- Have used anti-influenza virus drugs (oseltamivir, zanamivir, peramivir, favipiravir, abidol, baloxavir dipivoxil, amantadine, or diamond) within 2 weeks before screening Ethylamine, etc.);
- Acute respiratory infections, otitis media, sinusitis or other infectious diseases such as bronchitis, pneumonia, tuberculosis, etc. occurred within 2 weeks before screening, and are in the acute stage;
- Patients who also suffer from bacterial or viral infections and need systemic antibacterial or antiviral therapy
Key Trial Info
Start Date :
January 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2021
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT04736758
Start Date
January 8 2021
End Date
December 18 2021
Last Update
July 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China, 330006